You are about to leave this website and will be redirected to our online portal for healthcare professionals. By continuing, you confirm that you are a healthcare professional.
We are a fully integrated biotechnology company focused on discovering, developing, and commercializing innovative medicines. We are committed to improving patients’ lives worldwide by targeting diseases with high unmet needs. Our R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Our portfolio comprises discovery through to Phase 4 programs in immunology, oncology, and other indications. Our first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan.
We discover, develop and commercialize novel medicines to address unmet needs.
"Building on our strong fundamentals, we are taking the right steps to deliver on our core mission: adding years of life and improving the quality of life of patients globally."
Hear from Marina as she explains what she loves about her job. Want to discover your purpose at Galapagos?
We are conducting clinical trials in several inflammatory indications, fibrosis, kidney and metabolic diseases.
